BCL2 and prostate cancer: Previous studies in prostate cancer have also shown that miR-143-3p can inhibit cell growth through various targets, including KRAS [55], Bcl-2 [33], ERK5 [30], LIMK1 [58], HK2 [29] and KLK2 [36].